|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Walboomers JM, Jacobs MV, Manos MM, et al:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Muñoz N, Bosch FX, De Sanjosé S, et al:
Epidemiologic classification of human papillomavirus types
associated with cervical cancer. N Engl J Med. 348:518–527.
2003.
|
|
4.
|
Clifford GM, Smith JS, Plummer M, Muñoz N
and Franceschi S: Human papillomavirus types in invasive cervical
cancer worldwide: a meta-analysis. Br J Cancer. 88:63–73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Band V, Dalal S, Delmolino L and Androphy
EJ: Enhanced degradation of p53 protein in HPV-6 and BPV-1
E6-immortalized human mammary epithelial cells. EMBO J.
12:1847–1852. 1993.PubMed/NCBI
|
|
6.
|
Lechnerl MS, Mackl DH, Finicle AB, Crook
T, Vousden KH and Laiminsl LA: Human papillomavirus E6 proteins
bind p53 in vivo and abrogate p53-mediated repression of
transcription. EMBO J. 11:3045–3052. 1992.
|
|
7.
|
Thomas M, Pim D and Banks L: The role of
the E6-p53 interaction in the molecular pathogenesis of HPV.
Oncogene. 18:7690–7700. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Münger K and Howley PM: Human
papillomavirus immortalization and transformation functions. Virus
Res. 89:213–228. 2002.PubMed/NCBI
|
|
9.
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Nelson KM and WEiss GJ: MicroRNAs and
cancer: past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
12.
|
Kikkawa N, Hanazawa T, Fujimura L, et al:
miR-489 is a tumour-suppressive miRNA target PTPN11 in
hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer.
103:877–884. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Nohata N, Hanazawa T, Kikkawa N, et al:
Tumour suppressive microRNA-874 regulates novel cancer networks in
maxillary sinus squamous cell carcinoma. Br J Cancer. 105:833–841.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kano M, Seki N, Kikkawa N, et al: miR-145,
miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in
esophageal squamous cell carcinoma. Int J Cancer. 127:2804–2814.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Moriya Y, Nohata N, Kinoshita T, et al:
Tumor suppressive microRNA-133a regulates novel molecular networks
in lung squamous cell carcinoma. J Hum Genet. 57:38–45. 2012.
View Article : Google Scholar
|
|
16.
|
Hidaka H, Seki N, Yoshino H, Yamasaki T,
et al: Tumor suppressive microRNA-1285 regulates novel molecular
targets: aberrant expression and functional significance in renal
cell carcinoma. Oncotarget. 3:44–57. 2012.PubMed/NCBI
|
|
17.
|
Ichimi T, Enokida H, Okuno Y, et al:
Identification of novel microRNA targets based on microRNA
signatures in bladder cancer. Int J Cancer. 125:345–352. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yoshino H, Chiyomaru T, Enokida H, et al:
The tumoursuppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Kinoshita T, Hanazawa T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion through targeting laminin-332 in head and neck squamous
cell carcinoma. Oncotarget. 3:1386–1400. 2012.PubMed/NCBI
|
|
20.
|
Alajez NM, Lenarduzzi M, Ito E, et al:
MiR-218 suppresses nasopharyngeal cancer progression through
downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res.
71:2381–2391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Uesugi A, Kozaki K-I, Tsuruta T, et al:
The tumor suppressive microRNA miR-218 targets the mTOR component
Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res.
71:5765–5678. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Tie J, Pan Y, Zhao L, et al: MiR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Tatarano S, Chiyomaru T, Kawakami K, et
al: miR-218 on the genomic loss region of chromosome 4p15.31
functions as a tumor suppressor in bladder cancer. Int J Oncol.
39:13–21. 2011.PubMed/NCBI
|
|
24.
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Gravitt PE, Peyton CL, Alessi TQ, et al:
Improved amplification of genital human papillomaviruses. J Clin
Microbiol. 38:357–361. 2000.PubMed/NCBI
|
|
26.
|
Mattick JS: RNA regulation: a new
genetics? Nat Rev Genet. 5:316–323. 2004. View Article : Google Scholar
|
|
27.
|
Lee J-W, Choi CH, Choi J-J, et al: Altered
MicroRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Wang X, Tang S, Le S-Y, et al: Aberrant
expression of oncogenic and tumor-suppressive microRNAs in cervical
cancer is required for cancer cell growth. PLoS One. 3:e25572008.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Pereira PM, Marques JP, Soares AR, Carreto
L and Santos MAS: MicroRNA expression variability in human cervical
tissues. PLoS One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Li Y, Wang F, Xu J, et al: Progressive
miRNA expression profiles in cervical carcinogenesis and
identification of HPV-related target genes for miR-29. J Pathol.
224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Rao Q, Zhou H, Peng Y, Li J and Lin Z:
Aberrant microRNA expression in human cervical carcinomas. Med
Oncol. 29:1242–1248. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Li Y, Liu J, Yuan C, Cui B, Zou X and Qiao
Y: High-risk human papillomavirus reduces the expression of
microRNA-218 in women with cervical intraepithelial neoplasia. J
Int Med Res. 38:1730–1736. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Chiyomaru T, Enokida H, Kawakami K, et al:
Functional role of LASP1 in cell viability and its regulation by
microRNAs in bladder cancer. Urologic Oncol. 30:434–443. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Bartel DP, Lee R and Feinbaum R:
MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell.
116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Guess CM and Quaranta V: Defining the role
of laminin-332 in carcinoma. Matrix Biol. 28:445–455. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Marinkovich MP: Laminin 332 in
squamous-cell carcinoma. Nat Rev Cancer. 7:370–380. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Carter WG, Ryan MC and Gahr PJ: Epiligrin,
a new cell adhesion ligand for integrinα3β1 in epithelial basement
membranes. Cell. 65:599–610. 1991.
|
|
38.
|
Schenk S, Hintermann E, Bilban M, et al:
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated
during MMP-dependent mammary gland involution. J Cell Biol.
161:197–209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Okamoto O, Bachy S, Odenthal U, et al:
Normal human keratinocytes bind to the alpha3LG4/5 domain of
unprocessed laminin-5 through the receptor syndecan-1. J Biol Chem.
278:44168–44177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Mizejewski GJ: Role of integrins in
cancer: survey of expression patterns. Proc Soc Exp Biol Med.
222:124–138. 1999. View Article : Google Scholar : PubMed/NCBI
|
